Intracellular signalling downstream of the chemotactic CXCL12-CXCR4 axis, responsible for disrupted homing in CML, has been elucidated in LSCs, highlighting novel therapeutic opportunities. The gene discussed is CXCR4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.